Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.

ABSTRACT:

Background

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Given the chronic and heterogenous nature of the disease, treatment with various therapies is a frequent scenario in clinical practice. In persons with chronic morbidity such as MS patients, polypharmacy can give rise to considerable health problems.

Objectives

The aim of the present study was to examine the frequency of polypharmacy among relapsing-remitting (RR) MS patients as well as to analyse sociodemographic and clinical factors, which might be associated with polypharmacy (use of five or more medications). Differences in medication between MS patients with and without secondary illnesses (PwSI and Pw/oSI), between men and women and between patients with and without polyphar

SUBMITTER: Frahm N 

PROVIDER: S-EPMC6345436 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature